Where does Transmed7 LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Transmed7 LLC ranks #7,949 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Transmed7 LLC hold?

Transmed7 LLC holds 41 US utility patents granted between 2015 and 2025, spanning 7 technology areas.

What is Transmed7 LLC's Innovation Score?

Transmed7 LLC has an Innovation Score of 38.4 out of 100 (top 41% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Transmed7 LLC focus on?

Transmed7 LLC's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 41 patents, ranking #464 of 7,127 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is Transmed7 LLC's patent grant rate increasing or decreasing?

Transmed7 LLC's recent grant velocity is +17% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Transmed7 LLC's patents?

Transmed7 LLC's patents average 17.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Transmed7 LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Transmed7 LLC

USPTO PatentsView assignee record - 41 granted patents across 7 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Transmed7 ranks #7,949 of 49,997 tracked US assignees by granted-patent volume, with 41 patents across 7 technology areas.

#7,949
of 49,997 US assignees by volume: Top 41%
by Innovation Score (38.4/100): 17.3
avg claims per patent: +17%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7949 · US Corporation #7,949 · 41 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 41 grants
UPPER-Q #7,949/49,997
PHOTO-FINISH Talkdesk
CPC-NARROW A61B · 7 areas
INNOV-THIN 38.4/100
CLAIMS-RICH 17.3 claims/avg
TYPE-USCORP US Corporation
VEL-UP +17% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Talkdesk, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Transmed7’s 38.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.9 pts (34%) Velocity 5.7 pts (15%) Breadth 9.4 pts (24%) Claim depth 10.4 pts (27%)

Qualcomm Incorporated · highest

85
Con Edison Battery… · near

38
DePuy Mitek · near

38
DewertOkin · near

38
Par Pharmaceutical · near

38
Transmed7 · this assignee

38
3D Lighting… · lowest

7

What this shows Transmed7's Innovation Score is 38.4/100 (top 41% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Transmed7?

Each dot is one of Transmed7’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Transmed7’s own 17.3 claims/patent is at or below the 17.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Transmed7 vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Transmed7's grants concentrate

Transmed7 LLC is a focused PatentsView assignee: 7 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2018 (5 grants) versus a trough of 2 in 2017. By volume, Transmed7 sits between Talkdesk, Inc. and Universiteit Leiden.

Transmed7's three-year grant acceleration

Transmed7 LLC shows 12 grants in 2022–2024 against only 14 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Talkdesk

41
Tata Communicatio…

41
Thermo Fisher Sci…

41
Topera

41
Trimble AB

41
True Velocity

41
Twistlock

41
Universiteit Leid…

41
Transmed7 ◀

41

What this shows Transmed7 holds 41 patents at rank #7,950, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Transmed7

By rank, the assignees closest to #7,950 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Transmed7's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Transmed7, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Transmed7 ranks #464 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (38 here).

DewertOkin GmbH 38 Par Pharmaceutical, Inc. 38 Con Edison Battery Storage, LLC 38 DePuy Mitek, LLC 38

Transmed7's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 41% higher than 59% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Transmed7 LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	7.3%
2016	3	7.3%
2017	2	4.9%
2018	5	12.2%
2019	5	12.2%
2020	5	12.2%
2021	4	9.8%
2022	3	7.3%
2023	4	9.8%
2024	5	12.2%
2025partial year	2	4.9%

Which technologies does Transmed7 LLC patent most?

A61B - DIAGNOSIS; SURGERY; Identification 41

Y10T - Technical Subjects Covered BY Former US Classification 5

B23P - Metal-working NOT Otherwise Provided FOR; Combined OPERATIONS; Universal Machine Tools 5

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 4

G06F - Electric Digital Data Processing 3

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 3

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 2

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Transmed7 LLC's patent record in context - here's where to go next.

Transmed7 LLC's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #7,949 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Transmed7 LLC against Talkdesk, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 38.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.